These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7909502)

  • 41. The impact of decreasing urinary IgA levels on decreased bacteriuria in a rat model of ileal augmented bladder.
    Miura T; Tanaka K; Nakano Y; Arakawa S; Takenaka A; Fujisawa M
    J Urol; 2009 Jan; 181(1):372-8. PubMed ID: 19010498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili.
    Wright KJ; Seed PC; Hultgren SJ
    Cell Microbiol; 2007 Sep; 9(9):2230-41. PubMed ID: 17490405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of subinhibitory concentrations of antibacterial agents on the adherence of fimbriated Escherichia coli to uroepithelial cells].
    Padilla Espinosa C; Brevis P; Zemelman R; Vivaldi E
    Rev Latinoam Microbiol; 1988; 30(1):5-9. PubMed ID: 2902677
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of pap copy number and receptor specificity on virulence of fimbriated Escherichia coli in a murine urinary tract colonization model.
    Hull RA; Nowicki B; Kaul A; Runyan R; Svanborg C; Hull SI
    Microb Pathog; 1994 Aug; 17(2):79-86. PubMed ID: 7861959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects.
    Geerlings SE; Meiland R; van Lith EC; Brouwer EC; Gaastra W; Hoepelman AI
    Diabetes Care; 2002 Aug; 25(8):1405-9. PubMed ID: 12145242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Disturbance of the local vesicular defense as a cause of cystitis manifestation].
    Krüger C; Grande R; Wöhrmann W; Commichau R
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):321-6. PubMed ID: 4154604
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Langermann S; Palaszynski S; Barnhart M; Auguste G; Pinkner JS; Burlein J; Barren P; Koenig S; Leath S; Jones CH; Hultgren SJ
    Science; 1997 Apr; 276(5312):607-11. PubMed ID: 9110982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urinary tract infections: bacteriological aspects of recurrent cystitis].
    Fontana G; Savoia D; Cavallo G
    G Batteriol Virol Immunol; 1984; 77(1-6):33-44. PubMed ID: 6399273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication.
    Bates JM; Raffi HM; Prasadan K; Mascarenhas R; Laszik Z; Maeda N; Hultgren SJ; Kumar S
    Kidney Int; 2004 Mar; 65(3):791-7. PubMed ID: 14871399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PapG-adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infections of cynomolgus monkeys.
    Winberg J; Möllby R; Bergström J; Karlsson KA; Leonardsson I; Milh MA; Teneberg S; Haslam D; Marklund BI; Normark S
    J Exp Med; 1995 Dec; 182(6):1695-702. PubMed ID: 7500014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of antibodies to type 1 fimbriae on clearance of fimbriated Escherichia coli from the bloodstream of turkeys.
    Arp LH
    Am J Vet Res; 1985 Dec; 46(12):2644-7. PubMed ID: 2867723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of P fimbriae of uropathogenic Escherichia coli strains.
    Coşar G; Hoşgör M; Ozgenç O; Hilmioğlu S; Taşli H
    Infez Med; 2001 Jun; 9(2):98-100. PubMed ID: 12698022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice.
    Iwahi T; Abe Y; Nakao M; Imada A; Tsuchiya K
    Infect Immun; 1983 Mar; 39(3):1307-15. PubMed ID: 6132876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Environmental alteration and two distinct mechanisms of E. coli adherence to bladder epithelial cells.
    Avots-Avotins AE; Fader RC; Davis CP
    Invest Urol; 1981 Mar; 18(5):364-70. PubMed ID: 6110645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization against urinary tract infections.
    Uehling DT; Jensen J; Balish E
    J Urol (Paris); 1985; 91(1):23-6. PubMed ID: 3900224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemagglutination ability and adherence to the Buffalo green monkey kidney cell line of uropathogenic Escherichia coli.
    Vranes J
    APMIS; 1997 Nov; 105(11):831-7. PubMed ID: 9393553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice.
    Malaviya R; Ross E; Jakschik BA; Abraham SN
    J Clin Invest; 1994 Apr; 93(4):1645-53. PubMed ID: 7512987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro adherence of type 1-fimbriated uropathogenic Escherichia coli to human ureteral mucosa.
    Fujita K; Yamamoto T; Yokota T; Kitagawa R
    Infect Immun; 1989 Aug; 57(8):2574-9. PubMed ID: 2568346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamm-Horsfall protein acts as a general host-defense factor against bacterial cystitis.
    Raffi HS; Bates JM; Laszik Z; Kumar S
    Am J Nephrol; 2005; 25(6):570-8. PubMed ID: 16244464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux.
    Roberts JA; Suarez GM; Kaack B; Kallenius G; Svenson SB
    J Urol; 1985 Jun; 133(6):1068-75. PubMed ID: 2860250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.